Price T Rowe Associates Inc Generation Bio Co. Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Generation Bio Co. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 9,513,626 shares of GBIO stock, worth $21 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,513,626
Previous 8,878,361
7.16%
Holding current value
$21 Million
Previous $36.1 Million
25.75%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding GBIO
# of Institutions
83Shares Held
50MCall Options Held
100Put Options Held
200-
Atlas Venture Life Science Advisors, LLC8.28MShares$18.3 Million3.11% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.92MShares$8.66 Million0.18% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$7.28 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.98MShares$6.59 Million0.0% of portfolio
-
Artal Group S.A. Luxembourg, N42.83MShares$6.26 Million0.51% of portfolio
About Generation Bio Co.
- Ticker GBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,011,200
- Market Cap $130M
- Description
- Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...